NFKB1 and chronic obstructive pulmonary disease: In smokers with COPD, the levels and activities of HDAC2 are significantly reduced, leading to increased airway inflammation by promoting the expression of IL-17A [127] and/or the phosphorylation of Akt [128] and/or the activity of NF-κB [129].